buformin has been researched along with Carcinoma, Renal Cell in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isono, T | 1 |
| Chano, T | 1 |
| Yonese, J | 1 |
| Yuasa, T | 1 |
1 other study available for buformin and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas.
Topics: Acids; Buformin; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Epoxy Compounds; Flow Cytometr | 2016 |